MedTrace Logo

Postoperative Desogestrel for Endometriosis Related Pain

NCT01559480 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-04-09

No results posted yet for this study

Summary

Endometriosis is one of the most common disease in reproductive aged women.Surgical intervention has a significant symptoms relief. However, symptom recurrence is often after surgery. This study aims to determine the efficacy of Desogestrel compared with placebo in pain symptom of symptomatic endometriosis patient undergo conservative surgery . The primary outcome measurement is pain score at 6 months after surgery.

Conditions

  • Endometriosis

Interventions

DRUG

Desogestrel

Desogestrel 75 mcg Takes 1 capsule before bedtime for 6 months

DRUG

Placebo

Placebo capsule takes 1 capsule before bedtime for 6 months

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Prasong Tanmahasamut, M.D. · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559480 on ClinicalTrials.gov